Diagnosis & Disease Information


FDA: Nitrosamine Impurity Identified in Commonly Used Acid Suppressant

According to the Food and Drug Administration (FDA), a nitrosamine impurity, N-nitrosodimethylamine (NDMA), has been identified in some samples of ranitidine. NDMA was one of several nitrosamine impurities implicated in the massive recall of angiotensin II receptor blockers (ARBs) since last year.  NDMA is classified as a probable human carcinogen; the impurity was identified following…